List of Chelsea Therapeutics International patents

List of Chelsea Therapeutics International patents

List of Credence MedSystems patents

List of Confluera patents

List of Laszlo Systems patents

List of funding rounds for Adagio Therapeutics

List of SBIR/STTR awards granted to VIGILANT CYBER SYSTEMS, INC

Patents where

Current Assignee

Name

is

Chelsea Therapeutics International

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 8008285 Droxidopa and pharmaceutical composition thereof for the treatment of fibromyalgia	Patent 8008285 was granted and assigned to Chelsea Therapeutics International on August, 2011 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8008285	August 30, 2011
	‌ US Patent 8461205 Anthranilic acid derivatives	Patent 8461205 was granted and assigned to Chelsea Therapeutics International on June, 2013 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8461205	June 11, 2013
	‌ US Patent 7829708 Metabolically inert antifolates for treating disorders of abnormal cellular proliferation and inflammation	Patent 7829708 was granted and assigned to Chelsea Therapeutics International on November, 2010 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	7829708	November 9, 2010
	‌ US Patent 8658652 Antifolate combinations	Patent 8658652 was granted and assigned to Chelsea Therapeutics International on February, 2014 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8658652	February 25, 2014
	‌ US Patent 8383681 Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders or attention deficit disorders	Patent 8383681 was granted and assigned to Chelsea Therapeutics International on February, 2013 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8383681	February 26, 2013
	‌ US Patent 7951812 Substituted pyrrolo[2,3-d]pyrimidines as antifolates	Patent 7951812 was granted and assigned to Chelsea Therapeutics International on May, 2011 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	7951812	May 31, 2011
	‌ US Patent 8530653 Enzyme inhibiting compounds	Patent 8530653 was granted and assigned to Chelsea Therapeutics International on September, 2013 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8530653	September 10, 2013
	‌ US Patent 8158149 Threo-DOPS controlled release formulation	Patent 8158149 was granted and assigned to Chelsea Therapeutics International on April, 2012 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8158149	April 17, 2012
	‌ US Patent 8460705 Threo-DOPS controlled release formulation	Patent 8460705 was granted and assigned to Chelsea Therapeutics International on June, 2013 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8460705	June 11, 2013
	‌ US Patent 8263658 Anthranilic acid derivatives	Patent 8263658 was granted and assigned to Chelsea Therapeutics International on September, 2012 by the United States Patent and Trademark Office.		Chelsea Therapeutics International		United States Patent and Trademark Office	8263658	September 11, 2012

10 results

0 selected

10 results

0 selected